An open-label study to evaluate the potential pharmacokinetic interaction between PLA-695 [giripladib] and methotrexate when coadministered orally to adult subjects with rheumatoid arthritis

Trial Profile

An open-label study to evaluate the potential pharmacokinetic interaction between PLA-695 [giripladib] and methotrexate when coadministered orally to adult subjects with rheumatoid arthritis

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Dec 2007

At a glance

  • Drugs Giripladib (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 11 Dec 2007 Status changed from recruiting to completed.
    • 22 Oct 2007 New trial centres added.
    • 04 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top